Wednesday, September 26, 2012 Tuesday, September 25, 2012 Monday, September 24, 2012 Sunday, September 23, 2012 Friday, September 21, 2012- Mylan Receives FDA Approval and 4 Stocks Rising to 52-Week Highsat Wall St. Cheat Sheet (Fri, Sep 21)
- Merck Poised To Soar On New Insomnia Drugat Seeking Alpha (Fri, Sep 21)
- Eli Lilly And Stock Hits New 52-Week High (LLY)at TheStreet (Fri, Sep 21)
- Roche: A Leader In Biotech And Diagnostics, Part 2at Seeking Alpha (Fri, Sep 21)
- Vivus Shares Feel The Pain: Blockbuster Diet Drug Likely Won't Be Sold In Europeat Forbes (Fri, Sep 21)
- Dividend Hunting: Running Down Morningstar's Top 10 Picksat Seeking Alpha (Fri, Sep 21)
- Lilly's Cialis receives EU endorsement for new useAP (Fri, Sep 21)
- Carfilzomib Approved for Myeloma Therapy, Hepatitis C Treatments, Colorectal Cancer Drug Regorafenib Receives Approval, Phase III Trials for Hsp90 Inhibitor: Medical Breakthroughs are Powering Biotech Sector HigherWall Street Transcript (Fri, Sep 21)
- Healthcare Business Recap: Top Pharmas Form Non-Profit TransCelerateat Wall St. Cheat Sheet (Fri, Sep 21)
- 4 High Yield Stocks With Strong Fundamentalsat Seeking Alpha (Fri, Sep 21)
Thursday, September 20, 2012Add LLY News to My Yahoo!  | |
|